The effect of BIT225 on macrophage immune activation may prove useful, but so far BIT has no clinical data that any of the effects seen are either helpful for patients or sustained.
The second question is much easier to answer. BIT225 crosses the blood-brain barrier at the 1% level. While it is a bit abitary, 60% is often used as the threshold for a drug that to be considered to cross the BB barrier.
- Forums
- ASX - By Stock
- BIT
- $10 Billion Deal
$10 Billion Deal, page-1428
-
- There are more pages in this discussion • 11,840 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $41.50M |
Open | High | Low | Value | Volume |
4.4¢ | 4.7¢ | 4.4¢ | $31.64K | 708.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 259000 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 17361 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 259000 | 0.045 |
1 | 200000 | 0.044 |
4 | 438255 | 0.043 |
4 | 342000 | 0.042 |
4 | 287000 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 17361 | 1 |
0.047 | 225000 | 2 |
0.048 | 308915 | 1 |
0.050 | 21000 | 1 |
0.051 | 96225 | 3 |
Last trade - 14.10pm 21/06/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online